4　ⓔ文献

  1. 日本心身医学会教育研修委員会：心身医学の新しい診療指針．心身医学，1991; 31: 537–576.

  2. Engel GL: The need for a new medical model: a challenge for biomedicine. Science, 1977; 196: 129–136.

  3. Yoshiuchi K, Kumano H, et al: Stress and smoking were associated with Graves’ disease in women, but not in men. Psychosom Med, 1998; 60: 182–185.

  4. Whitehead WE, Crowell MD, et al: Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut, 1992; 33: 825–830.

  5. Nakahara R, Yoshiuchi K, et al: Prospective study on influence of psychosocial factors on glycemic control in Japanese patients with type 2 diabetes. Psychosomatics, 2006; 47: 240–246.

  6. 久保千春編：心身症．最新医学社，2013; 44–56.

  7. 小牧　元，久保千春，他編：心身症診断・治療ガイドライン2006，協和企画，2006.

  8. 吉内一浩，久保千春，他：DSM–5を理解するための基礎知識．食行動障害および摂食障害群．精神神経学雑誌，2014; 116: 626–628.

  9. 日本精神神経学会日本語版用語監修/髙橋三郎，大野　裕監訳：DSM–5® 精神疾患の分類と診断の手引，医学書院，2014; 206, 269, 270, 332, 338, 343.

  10. Hudson JI, Hiripi E, et al: The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry, 2007; 61: 348–358.

  11. Swanson SA, Crow SJ, et al: Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry, 2011; 68: 714–723.

  12. Treasure J, Claudino AM, et al: Eating disorders. Lancet, 2010; 375: 583–593.

  13. Cross–Disorder Group of the Psychiatric Genomics Consortium: Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell, 2019; 179: 1469–1482.

  14. Murray SB, Quintana DS, et al: Treatment outcomes for anorexia nervosa: a systematic review and meta-analysis of randomized controlled trials. Psychol Med, 2019; 49: 535–544.

  15. Zeeck A, Herpertz–Dahlmann B, et al: Psychotherapeutic treatment for anorexia nervosa: a systematic review and network Meta–Analysis. Front Psychiatry, 2018; 9: 158.

  16. Slade E, Keeney E, et al: Treatments for bulimia nervosa: a network meta–analysis. Psychol Med, 2018; 48: 2629–2636.

  17. Hilbert A, Petroff D, et al: Meta–analysis of the efficacy of psychological and medical treatments for binge–eating disorder. J Consult Clin Psychol, 2019; 87: 91–105.

  18. Lipsman N, Woodside DB, et al: Subcallosal cingulate deep brain stimulation for treatment–refractory anorexia nervosa: a phase 1 pilot trial. Lancet, 2013; 381: 1361–1370.

  19. Attia E, Steinglass JE, et al: Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry, 2019; 176: 449–456.

  20. Roy-Byrne PP, Craske MG, et al: Panic Disrder. Lancet, 2006; 368: 1023–1032.

  21. Schmidt NB, Keouph ME: Treatment of panic. Annu Rev Clin Psychol, 2010; 6: 241–256.

  22. 音羽健司，佐々木司，他：DSM–5を理解するための基礎知識．不安症群，強迫症および関連症群．精神神経学雑誌，2014; 116: 519–523.

  23. Kessler RC, Berglund P, et al: Lifetime prevalence and age–of–onset distributions of DSM–IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 2005; 62: 593–602.

  24. 川上憲人 (主任研究者)：こころの健康についての疫学調査に関する研究 (平成16〜18年度厚生労働科学研究費補助金 (こころの健康科学研究事業) こころの健康についての疫学調査に関する研究，総合研究報告書)，2007.

  25. Roy–Byrne PP, Geraci M, et al: Life events and the onset of panic disorder. Am J Psychiatry, 1986; 143: 1424–1427.

  26. Carpenter JK, Andrews LA, et al: Cognitive behavioral therapy for anxiety and related disorders: A meta–analysis of randomized placebo–controlled trials. Depress Anxiety, 2018; 35: 502–514.

  27. Otto MW, Tuby KS, et al: An effect–size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry, 2001; 158: 1989–1992.

  28. Stech EP, Lim J, et al: Internet–delivered cognitive behavioral therapy for panic disorder with or without agoraphobia: a systematic review and meta–analysis, Cogn Behav Ther, 2019: 1–24.

  29. 飛鳥井　望, 奥山眞紀子，他：DSM–5を理解するための基礎知識．心的外傷およびストレス因関連障害群．精神神経学雑誌，2014; 116: 702–706.

  30. Bremner JD, Randall P, et al: MRI–based measurement of hippocampal volume in patients with combat–related posttraumatic stress disorder. Am J Psychiatry, 1995; 152: 973–981.

  31. Karl A, Schaefer M, et al: A meta–analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev, 2006; 30: 1004–1031.

  32. Kilpatrick DG, Koenen KC, et al: The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane–exposed adults. Am J Psychiatry, 2007; 164: 1693–1699.

  33. Broekman BF, Olff M, et al: The genetic background to PTSD. Neurosci Biobehav Rev, 2007; 31: 348–362.

  34. Stein DJ, Ipser JC, et al: Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2006 ; CD002795.

  35. Cipriani A, Williams T, et al: Comparative efficacy and acceptability of pharmacological treatments for post–traumatic stress disorder in adults: a network meta–analysis. Psychol Med, 2018; 48: 1975–1984.

  36. National Institute for Clinical Excellence: Post–traumatic stress disorder: the management of PTSD in adults and children in primary and secondary care, Royal College of Psychiatrists and British Psychological Society, 2005.

  37. 日本トラウマティック・ストレス学会：PTSD初期対応マニュアル：プライマリケア医のために．2013. http://www.jstss.org/wp/wp-content/uploads/2013/09/JSTSS-PTSD初期対応マニュアル第1版.pdf

  38. Mavranezouli I, Megnin–Viggars O, et al: Psychological treatments for post–traumatic stress disorder in adults: a network meta–analysis. Psychol Med, 2020: 50: 542–555.

  39. Merz J, Schwarzer G, et al: Comparative efficacy and acceptability of pharmacological, psychotherapeutic, and combination treatments in adults with posttraumatic stress disorder: a network Meta–analysis. JAMA Psychiatry, 2019; 76: 904–913.

  40. Holland JC, Breitbart WS, et al eds: Psycho–oncology, Oxford University Press, 2010; 35–39.

  41. 内富庸介，小川朝生編：精神腫瘍学，医学書院，2011; 1–5.

  42. Uchitomi Y, Mikami I, et al: Depression after successful treatment for nonsmall cell lung carcinoma. Cancer, 2000; 89: 1172–1179.

  43. Akechi T, Okuyama T, et al: Major depression, adjustment disorders, and post–traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol, 2004; 22: 1957–1965.

  44. Miovic M, Block S: Psychiatric disorders in advanced cancer. Cancer, 2007; 110: 1665–1676.

  45. Yamauchi T, Inagaki M, et al: Death by suicide and other externally caused injuries following a cancer diagnosis: the Japan Public Health Center–based Prospective Study. Psychooncology, 2014; 23: 1034–1041.

  46. Wang YH, Li JQ, et al: Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta–analysis of cohort studies. Mol Psychiatry, 2020; 25: 1487–1499.

  47. Harashima S, Yoneda R, et al: Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 2019; 54: 1013–1021.